UK Cholesterol / Lipid Lowering Agents Market Analysis

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2623

  • Format: PPT, PDF

UK Lipid-lowering Drug Market: Segmented by Drug type (Statins, Bile acid sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, and others), Distribution channels (Hospital and Retail pharmacies)- Growth, Trends, and Forecasts (2019 – 2028)

Clear
SKU: 2623 Categories: ,

Report Overview

The UK Lipid lowering drug market size stood at around USD xx billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

The UK market is the world’s most potential market for lipid-lowering drugs and one of the fastest-growing markets in the world. The market size of UK’s lipid-lowering drugs will continue to expand, and the growth rate will gradually increase. UK’s lipid-lowering drug industry structure imported drugs have long occupied a relatively high proportion of the market. The overall prevalence of dyslipidemia in Chinese adults is as high as 40.4%. The increase in the population’s serum cholesterol level will lead to an increase of approximately 9.2 million cardiovascular events from 2010 to 2030.

Market Drivers

Growing prevalence of different cardiovascular diseases, which are caused by various factors such as increased obesity, changing food habits, higher alcohol consumption, and smoking is driving the cholesterol lowering drugs market. Growing awareness about bad cholesterol is one of the key drivers that is triggering the growth of the cholesterol lowering drugs market. Companies are referring investigational studies to understand which drugs are well-tolerated in patients and make improvements according to the results. Moreover, development of drug formulation for cholesterol lowering, new therapies such as emergence of PCSK9 inhibitors, and growing awareness about cardiovascular diseases are some of the major factors responsible for the growth of the cholesterol lowering drugs market.  Lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in industry.

1. UK Lipid lowering drugs Market Overview……………………………………………….
A. Market Size
2. Market Growth Drivers……………………………………………………………………..
A. Growing prevalence of cardiovascular diseases and sedentary lifestyle
B. Rising awareness about new drug development therapies
3. Major disease Areas……………………………………………………………………
A. Hypercholesterolemia
B. Cardiovascular diseases
C. Hyperlipidemia
4. Lipid/Cholesterol disease Market Segmentation……………………………………………
A. Drug class
I. Statins
II. Bile acid sequestrants
III. Cholesterol absorption inhibitors
IV. Fibric acid derivatives
V. PCSK9 Inhibitors
VI. Combination
VII. Others
B. Distribution channel
I. Hospital Pharmacies
II. Retail Pharmacies
5. Lipid lowering Drugs Major Products Market Share………………………………..
A. Key Findings
B. Market Analysis, Insights and Forecast
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. AstraZeneca Company overview, Product & Services, Strategies & Financials
B. Merck & Co. Company overview, Product & Services, Strategies & Financials
C. Pfizer Inc., Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Lipid lowering Drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug class:

Based on the drug class, the market is segmented based on Statins, Bile acid sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Combination, and others. The statins & combination segment dominated the cholesterol lowering drugs market in 2018. This segment is expected to dominate during the forecast period, owing to its better efficacy and cost effectiveness of this drug class. PCSK9 inhibitors is expected to be a more promising segment during the forecast period. It is anticipated to grow at a high CAGR from 2019 to 2027. Better tolerance, newly approved drugs in this class, and price revision by companies are some of the factors anticipated to drive the PCSK9 inhibitor segment during the forecast period.

By Distribution channels:

Based on distribution channels, the market is segmented into hospital and retail pharmacies. Hospital channel sales in the UK blood lipid-lowering drug market were accounting for xx%, three times the total size of retail pharmacies. With the continuous advancement of medical reform policies such as medical insurance control fees and bidding price limits, the market for blood lipid-lowering drugs in hospitals will become increasingly fierce, and the trend of outflow of blood lipid-lowering prescription drugs will become more obvious. Retail pharmacies, as the most important external channel, will directly benefit and there is still room for improvement in the proportion of retail pharmacies in the market for lowering blood lipids.

 

Top 5 Major Players

Some of the key players operating in the market are AstraZeneca; Merck & Co., Inc.; Pfizer, Inc.; DAIICHI SANKYO COMPANY, LIMITED; Amgen, Inc.; and Sanofi. Several companies, such as Esperion Therapeutics and CJ Healthcare, have promising drugs in the pipeline. Various companies, such as AstraZeneca; Merck & Co., Inc.; and Daiichi Sankyo, are poised to lose significant share due to patent expiration of drugs offered by them, which include Crestor, Zetia, Vytorin, and Welchol. Amgen and Sanofi are expected to witness healthy growth due to an increase in the usage of PCSK9 inhibitors such as Repatha and Praluent.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements